COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF
申请人:Sunovion Pharmaceuticals Inc.
公开号:US20140349992A1
公开(公告)日:2014-11-27
Provided herein are compounds and methods of synthesis thereof. The compounds set forth herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders, neurodegenerative disorders, neuropsychiatric disorders, disorders of cognition, learning or memory, gastrointestinal disorders, lower urinary tract disorder, and cancer. Compounds set forth herein modulate the activity of metabotropic glutamate receptor 5 (mGluR5) in the central nervous system or the periphery. Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.
Lukes; Grossmann, Collection of Czechoslovak Chemical Communications, 1936, vol. 8, p. 533,534, 537
作者:Lukes、Grossmann
DOI:——
日期:——
FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM
申请人:Bridgestone Corporation
公开号:EP1836238A1
公开(公告)日:2007-09-26
US8772301B2
申请人:——
公开号:US8772301B2
公开(公告)日:2014-07-08
[EN] FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM<br/>[FR] POLYMERES FONCTIONNALISES ET PNEUMATIQUES AMELIORES FABRIQUES A PARTIR DE CES DERNIERS
申请人:BRIDGESTONE CORP
公开号:WO2006076629A1
公开(公告)日:2006-07-20
[EN] A method of forming a functionalized polymer, the method comprising reacting a living polymer with a cyclic azasilacycle or cyclic azastannacycle. [FR] L'invention porte sur un procédé de formation d'un polymère fonctionnalisé, lequel procédé consiste à faire réagir un polymère vivant avec un azasilacycle cyclique ou un azastannacycle cyclique.